CME Sponsor:
Imedex

Location:
The Westin Diplomat
Hollywood, Florida  

Course Instructors:
Maria T. Abreu, MD
University of Miami Miller School of Medicine
Miami, Florida

Robert N. Baldassano, MD
University of Pennsylvania
Children’s Hospital of Philadelphia
School of Medicine
Philadelphia, Pennsylvania

Robert Burakoff, MD, MPH, FACG
Brigham and Women’s Hospital
Boston, Massachusetts

Russell D. Cohen, MD, FACG, AGAF
University of Chicago Medical Center
Chicago, Illinois

Sean P. Colgan, PhD
University of Colorado
Aurora, Colorado

Jean-Frédéric Colombel, MD
Hôpital Claude Huriez
Lille, France

Raymond K. Cross, Jr, MD, MS
University of Maryland School of Medicine
Baltimore, Maryland

Themistocles Dassopoulos, MD
Washington University School of Medicine
St. Louis, Missouri

Lee A. Denson, MD Cincinnati
Children’s Hospital Medical Center
Cincinnati, Ohio

Marla C. Dubinsky, MD
Cedars-Sinai Medical Center
Los Angeles, California

Sharon Dudley-Brown, PhD, FNP-BC
Johns Hopkins University
Schools of Medicine & Nursing
Baltimore, Maryland

Charles O. Elson, III, MD
University of Alabama at Birmingham
Birmingham, Alabama

Francis Farraye, MD, MSc, FACG
Boston University School of Medicine
Boston, Massachusetts

Ivan J. Fuss, MD
National Institutes of Health
Bethesda, Maryland

Matthew B. Grisham, PhD
Louisiana State University Health Sciences Center
Shreveport, Louisiana

Stephen B. Hanauer, MD, FACG
University of Chicago Medical Center
Chicago, Illinois

Hans Herfarth, MD, PhD
University of North Carolina at Chapel Hill
School of Medicine
Chapel Hill, North Carolina

Toshifumi Hibi, MD, PhD, FACG
Keio University School of Medicine
Shinjuku, Tokyo, Japan

Peter D. R. Higgins, MD, PhD, MSc
University of Michigan
Ann Arbor, Michigan

Jeffrey S. Hyams, MD
Connecticut Children’s Medical Center
Hartford, Connecticut

Christian Jobin, PhD
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Sunanda V. Kane, MD, MSPH, FACG
Mayo Clinic
Rochester, Minnesota

Michael D. Kappelman, MD, MPH
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Maureen Kelly, RN, MS, CNP
University of North Carolina at Chapel Hill
School of Nursing
Chapel Hill, North Carolina

Sandra C. Kim, MD
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Asher A. Kornbluth, MD
The Mount Sinai School of Medicine
New York, New York

Subra Kugathasan, MD
Emory University School of Medicine
Atlanta, Georgia

John H. Kwon, MD, PhD
University of Chicago Medical Center
Chicago, Illinois

James D. Lewis, MD, MSCE
University of Pennsylvania
Philadelphia, Pennsylvania

Gary R. Lichtenstein, MD, FACG
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

Edward V. Loftus, Jr, MD, FACG
Mayo Clinic
Rochester, Minnesota

Richard P. MacDermott, MD, MACG
Albany Medical College
Albany, New York

Uma Mahadevan, MD
University of California, San Francisco
San Francisco, California

Gil Y. Melmed, MD, MS
Cedars-Sinai Medical Center
University of California at Los Angeles School of Medicine
Los Angeles, California

Alan C. Moss, MD, FACG
Harvard Medical School
Boston, Massachusetts

Andrew S. Neish, MD
Emory University School of Medicine
Atlanta, Georgia

Mark T. Osterman, MD, MSCE
University of Pennsylvania
Abramson Cancer Center
Philadelphia, Pennsylvania

Charles A. Parkos, MD, PhD
Emory University School of Medicine
Atlanta, Georgia

Susan N. Peck, MSN, CRNP
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Scott Plevy, MD
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Daniel H. Present, MD, MACG
The Mount Sinai School of Medicine
New York, New York

Miguel Regueiro, MD
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania

Feza H. Remzi, MD
Cleveland Clinic
Cleveland, Ohio

Joel R. Rosh, MD, FACG, FAAP
Goryeb Children’s Hospital Atlantic Health
Morristown, New Jersey

David T. Rubin, MD, FACG
University of Chicago Medical Center
Chicago, Illinois

Michele Rubin, APN-CNS, CGRN
University of Chicago Medical Center
Chicago, Illinois

Paul E. Rutgeerts, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium

Maya Saleh, PhD
The Research Institute of the McGill University Health Centre
Montreal, Quebec, Canada

William J. Sandborn, MD, FACG
University of California San Diego
La Jolla, California

R. Balfour Sartor, MD
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Bruce E. Sands, MD, MS, FACG
The Mount Sinai Medical Center
New York, New York

David A. Schwartz, MD
Vanderbilt University Medical Center
Nashville, Tennessee

Bo Shen, MD, FACG
Cleveland Clinic
Cleveland, Ohio

Corey A. Siegel, MD, MS
Dartmouth Medical School
Dartmouth-Hitchcock Medical Center
Hanover, New Hampshire

Scott B. Snapper, MD, PhD
Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts

William J. Tremaine, MD, FACG
Mayo Clinic
Rochester, Minnesota

Thomas A. Ullman, MD, FACG
The Mount Sinai School of Medicine
New York, New York

Fernando S. Velayos, MD, MPH
University of California at San Francisco
San Francisco, California

Casey T. Weaver, MD
University of Alabama at Birmingham
Birmingham, Alabama

Betty J. White, RN, BSN, MN, ARNP
Digestive Health Specialists
Tacoma, Washington

Ramnik J. Xavier, MD, PhD
Massachusetts General Hospital
Boston, Massachusetts

Number of Credits:
18 AMA PRA Category 1 Credit™

Registration:
Early- payment received by 9/29/11
Physicians $349
PhD and PharmD $299

Discounted- payment received by 11/23
Physicians $449
PhD and PharmD $399

Regular- payment received after 11/23/11
Physicians $549
PhD and PharmD $499

Nurse practitioners and Physician assistants $150
(proof of eligibility must accompany registration and cannot be combined with any other discounts)

Nurses/Residents/Students $150
(proof of eligibility must accompany registration and cannot be combined with any other discounts)

Crohn’s and Colitis Foundation Member Discount -$75
(eligibility will be verified)
 
You may register online by November 23, 2011.  After that date, you must register onsite, but please call first to check if space is available. Registration confirmations will be issued before the meeting. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Group Discounts: Multiple registrants from the same institute or practice each receive a $50 discount off the published registration fees, provided all registration forms and payments are received together. Only one discount will apply per physician. Discounts are not available for the NP/PA, or nurses/residents/students rate.

Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.

For easy registration or any questions, feel free to call toll free at 1-855-276-6855.

Link

Detailed Description:
This activity is intended for gastroenterologists, pediatric gastroenterologists, IBD sub-specialists, internists, gastroenterology nurses, gastroenterology mid-level providers, gastrointestinal surgeons, clinical researchers, and other health care professionals with an interest in the treatment of pediatric and adult patients with inflammatory bowel disease. The goal is to provide practitioners with the information they need to optimize the care of their patients and to direct their attention to advances and breakthroughs in the field.

Learning Objectives:
After attending the clinical track at this conference, participants should be able to:
•    Describe recent clinical trial data regarding the next generation of biologic therapies in IBD
•    Comment on whether a family history of malignancy precludes the use of immunomodulators and biologics
•    Discuss whether internal fistulae should be treated first with medical or with surgical therapy
•    Analyze several alternative approaches to treating the refractory inpatient with severe IBD
•    Explain at least 1 advance in endoscopic procedures for IBD
•    Identify at least 3 advanced management strategies to select patients for treatment and to mitigate side effects
•    Describe at least 1 argument for and 1 argument against using drug levels to guide therapy in patients with IBD
•    Select the most appropriate pharmacologic therapy for pregnant patients
•    Restate at least 1 unanswered research question related to the basic science of IBD, especially genetics, immunology, or oncology
After attending the basic science track at this conference, participants should be able to:
•    Summarize at least 3 unanswered research questions related to the basic science of IBD, especially genetics, immunology, microbiology, or oncology
•    Comment on emerging basic science research in fields outside their own, especially genetics, immunology, microbiology, or oncology
•    Explain at least 1 recent advance in our understanding of regulatory T cells (Tregs) as they relate to IBD
•    Clarify our current understanding of how animal models do, or do not, contribute to success in drug development
•    Review the frontiers of scientific knowledge related to innate and adaptive immunity in IBD
After attending the pediatrics track at this conference, participants should be able to:
•    Summarize current best practices related to treating children with IBD, especially the use of immunomodulators and biologics
•    Choose from among several possible induction therapies for a hospitalized child with steroid refractory ulcerative colitis
•    Describe current research on the genetics of IBD in children
•    Comment on the optimum treatment sequence for a pediatric patient with severe inflammatory Crohn’s disease
After attending the nursing session at this conference, participants should be able to:
•    Discuss techniques to optimize enteral nutrition for pediatric patients
•    Comment on tools aimed at helping patients with IBD to optimize their healthcare